These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2106528)

  • 1. Effect of cholinergic muscarinic receptor blockade on human growth hormone (GH)-releasing hormone-(1-44)-induced GH secretion in anorexia nervosa.
    Tamai H; Komaki G; Matsubayashi S; Kobayashi N; Mori K; Nakagawa T; Truong MP; Walter RM; Kumagai LF
    J Clin Endocrinol Metab; 1990 Mar; 70(3):738-41. PubMed ID: 2106528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cholinergic muscarinic antagonist pirenzepine on GH response to GHRH 1-40 in patients with anorexia nervosa.
    Rolla M; Andreoni A; Belliti D; Ferdeghini M; Cristofani R; Müller EE
    Endocrinol Exp; 1990 Mar; 24(1-2):195-204. PubMed ID: 2113857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of cholinergic muscarinic receptors by pirenzepine and GHRH-induced GH secretion in the acute and recovery phase of anorexia nervosa and atypical eating disorders.
    Rolla M; Andreoni A; Belliti D; Cristofani R; Ferdeghini M; Müller EE
    Biol Psychiatry; 1991 Jun; 29(11):1079-91. PubMed ID: 1908328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosa.
    Gianotti L; Arvat E; Valetto MR; Ramunni J; Di Vito L; Maccagno B; Camanni F; Ghigo E
    Biol Psychiatry; 1998 Feb; 43(3):181-7. PubMed ID: 9494699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
    Devesa J; Diaz MJ; Tresguerres JA; Arce V; Lima L
    J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of desensitization by hexarelin to subsequent GH releasing hormone-mediated GH secretion in patients with anorexia nervosa.
    Popovic V; Micic D; Djurovic M; Obradovic S; Casanueva FF; Dieguez C
    Clin Endocrinol (Oxf); 1997 May; 46(5):539-43. PubMed ID: 9231048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa.
    Gianotti L; Rolla M; Arvat E; Belliti D; Valetto MR; Ferdeghini M; Ghigo E; Müller EE
    Biol Psychiatry; 1999 Feb; 45(3):334-9. PubMed ID: 10023511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine but not pyridostigmine, a cholinesterase inhibitor, enhances the GHRH-induced GH rise in patients with anorexia nervosa.
    Ghigo E; Arvat E; Gianotti L; Nicolosi M; Valetto MR; Avagnina S; Bellitti D; Rolla M; Müller EE; Camanni F
    Biol Psychiatry; 1994 Nov; 36(10):689-95. PubMed ID: 7880938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspects of the neuroendocrine control of somatotropic function in calorically restricted dogs and patients with eating disorders: studies with cholinergic drugs.
    Müller EE; Rolla M
    Psychiatry Res; 1996 Apr; 62(1):51-63. PubMed ID: 8739115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cholinergic muscarinic receptor blockade on human growth hormone (GH)-releasing hormone-(1-44)-induced GH secretion in acromegaly and type I diabetes mellitus.
    Pietschmann P; Schernthaner G; Luger A
    J Clin Endocrinol Metab; 1986 Aug; 63(2):389-93. PubMed ID: 3088023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state.
    Broglio F; Gianotti L; Destefanis S; Fassino S; Abbate Daga G; Mondelli V; Lanfranco F; Gottero C; Gauna C; Hofland L; Van der Lely AJ; Ghigo E
    Clin Endocrinol (Oxf); 2004 May; 60(5):592-9. PubMed ID: 15104562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic involvement in the growth hormone releasing hormone-induced growth hormone release: studies in normal and acromegalic subjects.
    Massara F; Ghigo E; Demislis K; Tangolo D; Mazza E; Locatelli V; Müller EE; Molinatti GM; Camanni F
    Neuroendocrinology; 1986; 43(6):670-5. PubMed ID: 3093909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic modulation of growth hormone-releasing hormone effects on growth hormone secretion in dementia.
    Murialdo G; Zerbi F; Filippi U; Tosca P; Fonzi S; Di Paolo E; Costelli P; Porro S; Polleri A; Savoldi F
    Neuropsychobiology; 1990-1991; 24(3):129-34. PubMed ID: 1983729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha 2-adrenoceptor sensitivity in anorexia nervosa: GH response to clonidine or GHRH stimulation.
    Brambilla F; Ferrari E; Cavagnini F; Invitti C; Zanoboni A; Massironi R; Catalano M; Cocchi D; Müller EE
    Biol Psychiatry; 1989 Feb; 25(3):256-64. PubMed ID: 2536561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of feeding on the ultradian variation of the growth hormone (GH) response to GH-releasing hormone in normal subjects and patients with obesity and anorexia nervosa.
    De Marinis L; Folli G; D'Amico C; Mancini A; Sambo P; Tofani A; Oradei A; Barbarino A
    J Clin Endocrinol Metab; 1988 Mar; 66(3):598-604. PubMed ID: 3127419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atropine blockade of growth hormone (GH)-releasing hormone-induced GH secretion in man is not exerted at pituitary level.
    Casanueva FF; Villanueva L; Dieguez C; Cabranes JA; Diaz Y; Szoke B; Scanlon MF; Schally AV; Fernandez-Cruz A
    J Clin Endocrinol Metab; 1986 Jan; 62(1):186-91. PubMed ID: 3079600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa.
    Gianotti L; Pincelli AI; Scacchi M; Rolla M; Bellitti D; Arvat E; Lanfranco F; Torsello A; Ghigo E; Cavagnini F; Müller EE
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2805-9. PubMed ID: 10946886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of free fatty acids and acipimox, a lipolysis inhibitor, on the somatotroph responsiveness to GHRH in anorexia nervosa.
    Gianotti L; Fassino S; Daga GA; Lanfranco F; De Bacco C; Ramunni J; Arvat E; MacCario M; Ghigo E
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):713-20. PubMed ID: 10848875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
    Cordido F; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1989 Feb; 68(2):290-3. PubMed ID: 2493023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone and prolactin response to growth hormone-releasing in anorexia nervosa.
    Lomeo A; Mazzocchi G; Sessarego P; Torre R; Delmonte P; Giusti M
    Recenti Prog Med; 1989 Nov; 80(11):569-73. PubMed ID: 2516349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.